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Background & Objectives: Inflammatory bowel disease (IBD) is a severe inflammation in 
the gastrointestinal tract and consists of two forms:  ulcerative colitis (UC) and Crohn’s 
disease (CD). Probiotics have anti-inflammatory properties for curing gastrointestinal 
disorders like inflammatory bowel disease (IBD). Gram positive lactic acid bacteria such as 
Lactobacilli strains and Bifidobacteria strains are  primary microorganisms that classified as 
probiotics. Previous studies showed that Lactobacillus casei and  Bifidobacterium bifidum 
reduced the levels of inflammatory biomarkers and modulate immune responses on murine 
models of colitis, separately. The aim of this study was to investigate the synergistic anti-
inflammatory effects of whey cultured L. casei and B. bifidum on IBD management.  
Methods: In our study we cultured L.caseiand, B.bifidum in whey, separately and then 
combined these probiotics together and administered orally to male Wiastar rats for 10 days. 
Colitis was induced by rectal instillation of trinitrobenzene sulphonic acid (TNBS). Animals 
were divided into 5 groups  included normal (non-colitis), negative control (without any 
treatment), positive control (dexamethasone, 1 mg/kg/day, orally), prevention (1×108 cfu L. 
casei and 1×108 cfu B. bifidum/day, 10 days before TNBS-induced colitis), treatment (1×108 
cfu L. casei and 1×108 cfu B. bifidum/day, 10 days after TNBS-induced colitis). Biopsy 
specimens were obtained from distal colon and then inflammatory markers consisting of 
tumor necrosis factor-α (TNF-α), myeloperoxidase (MPO) and lipid peroxidation (LPO) were 
identified. 
Results: In treatment group, macroscopic scores reduced significantly and levels of TNF-α, 
MPO and LPO decreased but prevention group did not show positive effect to ameliorate 
colonic lesions. 
Conclusion: These data indicated that combination of L. casei and B. bifidum could alleviate 
colon damage and inflammatory markers in treatment colitis. Additional studies required to 
define the role of another probiotics combination to improve IBD. 
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